首页> Journal of controlled release : official journal of the Controlled Release Society> Camel milk extracellular vesicles-mediated co-delivery of siVEGF/sorafenib enhances the anti-hepatocellular carcinoma activity by dual-effect blocking the biological effects of VEGF.

Camel milk extracellular vesicles-mediated co-delivery of siVEGF/sorafenib enhances the anti-hepatocellular carcinoma activity by dual-effect blocking the biological effects of VEGF.

导出 LinkOut

翻译打印收藏纠错

第一作者： Feng,Chen

第一单位： Department of Biopharmaceutical Sciences, Shanghai Ocean University, Shanghai 201306, China.

作者： Feng,Chen ^[1] ; Yichen,Pan ^[1] ; Zhou,Fang ^[1] ; Mengdi,Song ^[1] ; Wang,Zhang ^[1] ; Hui,Yuan ^[1] ; Xinran,Gao ^[1] ; Min,Zhang ^[2] ; Kehai,Liu ^[3]

作者单位： Department of Biopharmaceutical Sciences, Shanghai Ocean University, Shanghai 201306, China. ^[1] Department of Biopharmaceutical Sciences, Shanghai Ocean University, Shanghai 201306, China; Marine Biomedical Science and Technology Innovation Platform of Lin-gang Special Area, Shanghai 201306, China; International Research Center for Food and Health, Shanghai Ocean University, Shanghai 201306, China. Electronic address: zhangmin@shou.edu.cn. ^[2] Department of Biopharmaceutical Sciences, Shanghai Ocean University, Shanghai 201306, China; Marine Biomedical Science and Technology Innovation Platform of Lin-gang Special Area, Shanghai 201306, China. Electronic address: khliu@shou.edu.cn. ^[3]

关键词 Extracellular vesicles Hepatocellular carcinoma Sorafenib siRNA delivery